Alpha Tau Medical Ltd.
NASDAQAlpha Tau Medical reports Tuesday after the bell, entering the print off a sharp rally that has now stretched to 14% over the past week and roughly 7% on the month, with the stock at $13.60. The most telling pre-earnings signal isn't positioning — it's the CFO's behaviour. Raphi Levy sold shares in at least ten separate transactions between late June and early July, offloading more…
DRTS short interest surges 47% in one week to 1.96% of float as shares available to borrow tighten sharply post-earnings, signaling accelerating short positioning into recent weakness.
Alpha Tau Medical reports Tuesday after the bell, entering the print off a sharp rally that has now stretched to 14% over the past week and roughly 7% on the month, with the stock at $13.60. The most telling…
Alpha Tau Medical enters the final stretch before its August 12 earnings with a continued divergence between relentless CFO selling and a stock that refuses to break down. The CFO storyline has only deepened since the…
Snapshot as of 25 Sept 2026
Alpha Tau Medical heads into the final days of July with a striking divergence: the borrow market has loosened sharply since last week's note, yet the CFO's sell programme shows no signs of stopping. The most notable…
Alpha Tau Medical has spent the past month staging an impressive rally — and its own CFO has been selling into every uptick. The insider angle is the week's most telling signal. CFO Raphi Levy has executed at least ten…
Alpha Tau Medical has delivered a week that splits neatly into two stories: an earnings print that moved the stock higher on the day, and a subsequent sell-off that has wiped nearly 14% off the price — with short…
Alpha Tau Medical heads into its June 2 results with a wave of fresh analyst conviction that sharply contrasts with the stock's turbulent recent price action. The analyst story is the standout here. Barclays initiated…
DRTS heads into its May 26 earnings print with the Street actively raising targets and borrowing conditions tightening further — a combination that sharpens attention on what the next clinical update delivers. The…
DRTS heads into today's earnings print having gained 22% in a single week — while nearly every comparable medical device name fell sharply. That outperformance stands out. The stock closed at $10.36 on May 15, up 32%…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DRTS — free to start on ORTEX.
Sign up for free →Open DRTS on ORTEX